It has been shown that in preclinical models, competitive inhibitors of the DNA Damage repair (DDR) genes ATM and ATR Kinase sensitizes NSCLC brain metastasis to radiation therapy24. This evidence concerns the gene ATM and non-small cell lung carcinoma.